Morgan Stanley Raises Globe Life Price Target to $127

Morgan Stanley analyst Bob Huang raised the price target on Globe Life (GL) to $127 from $125 and keeps an Equal Weight rating on the shares.

Morgan Stanley analyst Bob Huang has increased the price target for Globe Life (NYSE:GL) to $127, up from $125, while maintaining an Equal Weight rating on the shares [1]. The update comes amidst a wave of positive analyst sentiment surrounding the insurance giant, with several other firms also raising their price targets and ratings.

Analysts at Truist Financial, for instance, started coverage on Globe Life with a "buy" rating and a $150.00 price target, indicating a potential upside of 24.22% from the company's previous close [2]. Meanwhile, JPMorgan Chase & Co. boosted their price target to $160.00, and Wall Street Zen upgraded the stock from a "hold" to a "buy" rating.

These moves come on the heels of Globe Life's latest earnings report, where the company reported $3.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates by $0.17. However, the company's revenue grew by 4.5% year-over-year, and analysts predict a 13.87 EPS for the current year.

Globe Life's stock has seen significant insider activity, with CEO Frank M. Svoboda selling 6,019 shares in a transaction disclosed on May 20th. Additionally, institutional investors have been active, with hedge funds like Norges Bank and Nuveen LLC increasing their stakes in the company.

Despite these positive developments, Globe Life's stock has been volatile, trading down 1.9% on Monday, July 14th, to reach $118.37. The stock's 50-day and 200-day moving averages are $120.95 and $121.31, respectively, indicating a slight downward trend in the short term.

References:
[1] https://www.marketbeat.com/instant-alerts/globe-life-nysegl-stock-price-expected-to-rise-morgan-stanley-analyst-says-2025-07-14/
[2] https://www.marketbeat.com/instant-alerts/globe-life-nysegl-earns-buy-rating-from-analysts-at-truist-financial-2025-07-15/